ERIC HALL

Profile

First Name

: ERIC

Middle Name

:

Last Name

: HALL

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

SO GOOD BRAND, INC.

NEDA DANESHZADEH, RITA KATONA, RONALD OTTEN, KENT PILAKOWSKI, MICHAEL SIGEL, ALICIA SONTAG

EXECUTIVE OFFICER

SITE 10.01, INC.

CLEVE ADAMS, THAD BUCK, THOMAS DEBACCO, TIMOTHY S DUNN, TIMOTHY S. DUNN, MATTHEW FERGUSON, PETER FIACCO, CASEY S HALSEY, CASEY S. HALSEY, JASON LEHTINEN, GREG NOOK, SAGE OSTERFELD, KEVIN RAUCKMAN, SAM ROBERTSON, KEITH STEWART, HENRY WONG

EXECUTIVE OFFICER

RAPT THERAPEUTICS, INC.

DIRK BROCKSTEDT, MICHAEL GIORDANO, MICHAEL F. GIORDANO, DAVID GOEDDEL, DAVID V. GOEDDEL, MARY ANN V. GRAY, REKHA HEMRAJANI, WILLIAM HO, PAUL KASSNER, LINDA KOZICK, TIM LIN, LORI LYONS-WILLIAMS, WILLIAM J. RIEFLIN, WENDYE ROBBINS, BETH SEIDENBERG, BRIAN WONG, DAVID WUSTROW, RODNEY YOUNG

EXECUTIVE OFFICER

CRESCENT CREDIT OPPORTUNITIES FUND (CAYMAN), L.P.

MARK ATTANASIO, JASON BREAUX, JEAN-MARC CHAPUS, - CRESCENT CREDIT OPPORTUNITIES, LLC, JOHN FEKETE, WAYNE HOSANG, ROSS SLUSSER, RICHARD STEVENSON

EXECUTIVE OFFICER

CRESCENT CREDIT OPPORTUNITIES FUND AIF SCSP

MARK ATTANASIO, JASON BREAUX, JEAN-MARC CHAPUS, - CRESCENT CREDIT OPPORTUNITIES GP, S.A R.L., JOHN FEKETE, WAYNE HOSANG, ROSS SLUSSER, RICHARD STEVENSON

EXECUTIVE OFFICER

CRESCENT CREDIT OPPORTUNITIES FUND, L.P.

MARK ATTANASIO, JASON BREAUX, JEAN-MARC CHAPUS, - CRESCENT CREDIT OPPORTUNITIES, LLC, JOHN FEKETE, WAYNE HOSANG, ROSS SLUSSER, RICHARD STEVENSON

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2020-03-20

D

MANUFACTURING

DECLINE TO DISCLOSE

Equity

2020-11-04

D/A

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2018-12-18

D

MANUFACTURING

DECLINE TO DISCLOSE

Equity

2016-10-05

D

OTHER TECHNOLOGY

$1 - $1,000,000

Equity

2016-09-20